BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37642311)

  • 21. Cell Line-Dependent Variability of Coordinate Expression of p75NTR and CRABP1 and Modulation of Effects of Fenretinide on Neuroblastoma Cells.
    Yang YP; Wang S; Li X; Schor NF
    Oxid Med Cell Longev; 2016; 2016():7568287. PubMed ID: 26843908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin gallate inhibits growth and epithelial-to-mesenchymal transition in human thyroid carcinoma cell lines.
    De Amicis F; Perri A; Vizza D; Russo A; Panno ML; Bonofiglio D; Giordano C; Mauro L; Aquila S; Tramontano D; Andò S
    J Cell Physiol; 2013 Oct; 228(10):2054-62. PubMed ID: 23553645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LINC01816 promotes the migration, invasion and epithelial‑mesenchymal transition of thyroid carcinoma cells by sponging miR‑34c‑5p and regulating CRABP2 expression levels.
    Zhao H; Zhu X; Luo Y; Liu S; Wu W; Zhang L; Zhu J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.
    Zhao X; Hu X
    J Cell Physiol; 2019 Nov; 234(11):20992-21004. PubMed ID: 31093972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockdown of BAG3 induces epithelial-mesenchymal transition in thyroid cancer cells through ZEB1 activation.
    Meng X; Kong DH; Li N; Zong ZH; Liu BQ; Du ZX; Guan Y; Cao L; Wang HQ
    Cell Death Dis; 2014 Feb; 5(2):e1092. PubMed ID: 24577090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. All-trans retinoic acid attenuates isoproterenol-induced cardiac dysfunction through Crabp1 to dampen CaMKII activation.
    Park SW; Nhieu J; Lin YW; Wei LN
    Eur J Pharmacol; 2019 Sep; 858():172485. PubMed ID: 31238067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOSTDC1 inhibits follicular thyroid cancer cell proliferation, migration, and EMT via suppressing PI3K/Akt and MAPK/Erk signaling pathways.
    Zhou Q; Chen J; Feng J; Xu Y; Zheng W; Wang J
    Mol Cell Biochem; 2017 Nov; 435(1-2):87-95. PubMed ID: 28551845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH; Xiong F; Wang JP; Li JH; Zhong M; Liu QL; Luo GQ; Yang XJ; Xiao N; Xie B; Xiao H; Liu RJ; Dong CS; Wang KS; Wen JF
    PLoS One; 2014; 9(6):e99922. PubMed ID: 24945379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells.
    Lim WC; Kim H; Ko H
    J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing SIX1 inhibits epithelial mesenchymal transition through regulating TGF-β/Smad2/3 signaling pathway in papillary thyroid carcinoma.
    Min WP; Wei XF
    Auris Nasus Larynx; 2021 Jun; 48(3):487-495. PubMed ID: 33077306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).
    Zanetti A; Affatato R; Centritto F; Fratelli M; Kurosaki M; Barzago MM; Bolis M; Terao M; Garattini E; Paroni G
    J Biol Chem; 2015 Jul; 290(29):17690-17709. PubMed ID: 26018078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGFβ induces epithelial-mesenchymal transition of thyroid cancer cells by both the BRAF/MEK/ERK and Src/FAK pathways.
    Baquero P; Jiménez-Mora E; Santos A; Lasa M; Chiloeches A
    Mol Carcinog; 2016 Nov; 55(11):1639-1654. PubMed ID: 26392228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TIMP1 and SERPIN-A overexpression and TFF3 and CRABP1 underexpression as biomarkers for papillary thyroid carcinoma.
    Hawthorn L; Stein L; Varma R; Wiseman S; Loree T; Tan D
    Head Neck; 2004 Dec; 26(12):1069-83. PubMed ID: 15515157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells.
    Chen XH; Liu ZC; Zhang G; Wei W; Wang XX; Wang H; Ke HP; Zhang F; Wang HS; Cai SH; Du J
    Mol Immunol; 2015 May; 65(1):34-42. PubMed ID: 25618241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-
    Nagpal I; Wei LN
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31344789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined treatment with troglitazone and lovastatin inhibited epidermal growth factor-induced migration through the downregulation of cysteine-rich protein 61 in human anaplastic thyroid cancer cells.
    Chin LH; Hsu SP; Zhong WB; Liang YC
    PLoS One; 2015; 10(3):e0118674. PubMed ID: 25742642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA 483-3p targets Pard3 to potentiate TGF-β1-induced cell migration, invasion, and epithelial-mesenchymal transition in anaplastic thyroid cancer cells.
    Zhang X; Liu L; Deng X; Li D; Cai H; Ma Y; Jia C; Wu B; Fan Y; Lv Z
    Oncogene; 2019 Jan; 38(5):699-715. PubMed ID: 30171257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRABP1 in Non-Canonical Activities of Retinoic Acid in Health and Diseases.
    Nhieu J; Lin YL; Wei LN
    Nutrients; 2022 Apr; 14(7):. PubMed ID: 35406141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X; Hu Y; Dai L; Wang Y; Zhou J; Wang W; Di W; Qiu L
    PLoS One; 2014; 9(5):e96718. PubMed ID: 24816687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of the tumor suppressor gene retinoic acid receptor beta2 through the phosphoinositide 3-kinase/Akt signaling pathway.
    Lefebvre B; Brand C; Flajollet S; Lefebvre P
    Mol Endocrinol; 2006 Sep; 20(9):2109-21. PubMed ID: 16613989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.